Physician profile
Alfonso E Martinez
NPI 1013192798
$1,659.51
in general payments reported to CMS, 2019-2025
20 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.28 · 2021: $27.46 · 2022: $97.30 · 2023: $676 · 2024: $540 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $183.57 | 2019-2025 | |
| Novo Nordisk INC | $169.06 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $168.09 | 2023-2024 | Aveir, Jot Dx |
| Amgen INC. | $166.08 | 2019-2024 | Evenity, Repatha, Otezla |
| Neurelis, INC. | $156.33 | 2022-2024 | Valtoco |
| Bayer Healthcare Pharmaceuticals INC. | $136.88 | 2023-2025 | |
| Medtronic, INC. | $113.13 | 2024 | Turbohawk |
| Kci USA, INC. | $99.95 | 2023 | Activ.A.C. |
| Novartis Pharmaceuticals Corporation | $93.30 | 2019-2024 | |
| Vanda Pharmaceuticals INC. | $83.52 | 2023 | Fanapt, Hetlioz |
| Lilly USA, LLC | $55.87 | 2019-2025 | Mounjaro, Zepbound |
| Sunovion Pharmaceuticals INC. | $45.93 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $44.90 | 2023-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $27.36 | 2022-2024 | Farxiga |
| Abbvie INC. | $24.70 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $24.16 | 2025 | Daxxify |
| Dexcom, INC. | $21.97 | 2024 | Dexcom G6 Transmitter |
| Urovant Sciences INC | $17.76 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.59 | 2025 | Lifevest |
| Allergan, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfonso Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.